• Archives of Plastic Surgery
• /
• 제48권3호
• /
• pp.295-304
• /
• 2021

Clinical photography is an essential component of patient care in plastic surgery. The use of unsecured smartphone cameras, digital cameras, social media, instant messaging, and commercially available cloud-based storage devices threatens patients' data safety. This paper Identifies potential risks of clinical photography and heightens awareness of safe clinical photography. Specifically, we evaluated existing risk-mitigation strategies globally, comparing them to industry standards in similar settings, and formulated a framework for developing a risk-mitigation plan for avoiding data breaches by identifying the safest methods of picture taking, transfer to storage, retrieval, and use, both within and outside the organization. Since threats evolve constantly, the framework must evolve too. Based on a literature search of both PubMed and the web (via Google) with key phrases and child terms (for PubMed), the risks and consequences of data breaches in individual processes in clinical photography are identified. Current clinical-photography practices are described. Lastly, we evaluate current risk mitigation strategies for clinical photography by examining guidelines from professional organizations, governmental agencies, and non-healthcare industries. Combining lessons learned from the steps above into a comprehensive framework that could contribute to national/international guidelines on safe clinical photography, we provide recommendations for best practice guidelines. It is imperative that best practice guidelines for the simple, safe, and secure capture, transfer, storage, and retrieval of clinical photographs be co-developed through cooperative efforts between providers, hospital administrators, clinical informaticians, IT governance structures, and national professional organizations. This would significantly safeguard patient data security and provide the privacy that patients deserve and expect.

• Asian Pacific Journal of Cancer Prevention
• /
• 제15권17호
• /
• pp.7137-7139
• /
• 2014

Background: This systemic analysis was conducted to evaluate the efficacy and safety of pemetrexed based chemotherapy in treating patients with metastatic gastric cancer (MGC) as a salvage chemotherapy. Methods: Clinical studies evaluating the efficacy and safety of pemetrexed based regimens on response and safety for patients with gastric cancer were identified by using a predefined search strategy. Pooled response rates (RRs) of treatment were calculated. Results: In pemetrexed based regimens, 4 clinical studies including 171 patients with advanced gastric cancer were considered eligible for inclusion. Systemic analysis suggested that, in all patients, pooled RR was 25.1% (43/171) in pemetrexed based regimens. Major adverse effects were neutropenia, anorexia, fatigue, and anemia. No treatment related death occurred in pemetrexed based treatment. Conclusion: This systemic analysis suggests that pemetrexed based regimens are associated with mild activity with good tolerability in treating patients with MGC.

• Journal of Ginseng Research
• /
• 제34권4호
• /
• pp.264-273
• /
• 2010

While ginseng is reported to have a wide array of applications, there is growing evidence for its indications in diabetes and vascular disease. A clear connection, however, has not been established between ginseng's composition, dose and its targeted efficacy in humans. We therefore developed and initiated the Korean Red Ginseng Clinical Testing Program for diabetes and vascular function which is an efficacy and safety-based clinical screening model for ginseng. The most efficacious sources, ginsenoside profiles, doses, and modes of administration were examined in sequential, acute, followed by long term, randomized-controlled trials to investigate the efficacy and safety profiles. This review discusses the current state of the clinical research of Korean red ginseng program conducted in Toronto, paving the way for the use of clinically selected ginseng and its ginsenoside fractions in the management of diabetes and vascular diseases.

• 대한임상약리학회:학술대회논문집
• /
• 대한임상약리학회 1997년도 정기총회 및 추계학술대회
• /
• pp.27-27
• /
• 1997

• 대한임상약리학회:학술대회논문집
• /
• 대한임상약리학회 2007년도 추계학술대회
• /
• pp.86-86
• /
• 2007

See Full Text

• 임상간호연구
• /
• 제30권2호
• /
• pp.139-146
• /
• 2024

Purpose: This study aimed to examine the effects of the nursing work environment and self-efficacy on medical safety competence of nurses in general hospital. Methods: Participants included 183 nurses who were recruited through convenience sampling in a general hospital in South Korea. Questionnaires were collected from August 25 to September 22, 2023. The nursing work environment, self-efficacy and medical safety competence scales were used to assess the study variables. The t-test, one-way ANOVA, Scheffé test, Pearson correlation coefficients, and multiple regression tests were performed using IBM SPSS ver. 26.0. Results: Statistically significant correlations were found between nurses' medical safety competence and nursing work environment (r=.34, p<.001), and self-efficacy (r=.48, p<.001). Self-efficacy (β=.38, p<.001), nursing work environment (β=.25, p<.001), and clinical experience (β=.14, p=.043) had the greatest effect on nurses' medical safety competence (F=21.21, p<.001), with an explanatory power of 30.0%. Conclusion: This study confirmed that the nursing work environment and nurses' self-efficacy have a significant impact on nurses' medical safety competence. In order to implement patient safety in hospitals, it is necessary to develop and apply strategies to improve the nursing work environment and increase nurses' self-efficacy to enhance their medical safety capabilities.

• 한국응용약물학회:학술대회논문집
• /
• 한국응용약물학회 2006년도 Proceedings of The Convention
• /
• pp.139-145
• /
• 2006

Kaneka Corporation (Kaneka) has been manufacturing CoQ10 under GMP regulation since 1977. Kaneka has a sophisticated quality control system and has been supplying high quality CoQ10 materials to the worldwide customers (Kaneka CoQ10) for about 30 years. Kaneka CoQ10 is characterized by a lot of safety data, which are derived from clinical trials with healthy volunteers (single-dose and 4-week multi-dose safety studies), animal studies (13-week sub-chronic study in dogs and 52-week chronic study in rats), three types of mutagenicity test, six type of skin irritation test (for cosmetics), and others. The risk assessment of CoQ10 was performed by Council for Responsible Nutrition (USA). They reviewed many of available clinical data including clinical trials using Kaneka Q10, and concluded that the upper level for supplements (ULS) of CoQ10 is 1,200 mg/day (Hathcock and Shao. 2006, Regulatory Toxicology and Pharmacology, 45, 282 - 288).

• 한국약용작물학회:학술대회논문집
• /
• 한국약용작물학회 2006년도 Proceedings of The Convention of The Korean Society of Applied Pharmacology
• /
• pp.139-145
• /
• 2006

Kaneka Corporation (Kaneka) has been manufacturing CoQ10 under GMP regulation since 1977. Kaneka has a sophisticated quality control system and has been supplying high quality CoQ10 materials to the worldwide customers (Kaneka CoQ10) for about 30 years. Kaneka CoQ10 is characterized by a lot of safety data, which are derived from clinical trials with healthy volunteers (single-dose and 4-week multi-dose safety studies), animal studies (13-week sub-chronic study in dogs and 52-week chronic study in rats), three types of mutagenicity test, six type of skin irritation test (for cosmetics), and others. The risk assessment of CoQ10 was performed by Council for Responsible Nutrition (USA). They reviewed many of available clinical data including clinical trials using Kaneka Q10, and concluded that the upper level for supplements (ULS) of CoQ10 is 1,200mg/day (Hathcock and Shao. 2006, Regulatory Toxicology and Pharmacology, $\underline{45}$, 282 - 288).

• 한국독성학회:학술대회논문집
• /
• 한국독성학회 1997년도 국제심포지움 및 추계학술대회
• /
• pp.16-27
• /
• 1997

• 한국직업건강간호학회지
• /
• 제23권2호
• /
• pp.67-79
• /
• 2014

Purpose: The purpose of this study was to review the articles and theses on the patient safety culture of clinical nurses for identifying overall research trends regarding patient safety culture among hospital nurses, and to suggest strategies for improving nursing work environment related to patient safety culture. Methods: The subjects for this study were 17 articles selected according to inclusion criteria from five databases in Korea. Results: Seven articles were collected from nursing journals and ten from master's theses. The studies on the 17 articles were conducted at 66 hospitals from seven regions of Korea. The tools for patient safety culture were selected among the three tools from AHRQ and two Korean translation tools. The mean score of patient safety culture was 3.43. Conclusion: The findings from the article review indicate that, in order to improve nursing work environment for patient safety culture, the hospital and nursing manager should emphasize the education for patient safety, communication and open-minded reporting, and cooperation among the departments of hospital.